Showing 1 posts of 1 posts found.
Navidea Biopharmaceuticals, a developer of immunodiagnostic agents and immunotherapeutics, has announced that they will enter into a definitive asset purchase …
PinPoint signs laboratory partnership to expand access to AI cancer risk test
NHS expands community ear and hearing pathway across 10 ICBs
London secures major investment to accelerate healthcare innovation
People with severe mental illness more likely to die early from cardiovascular disease, report finds
Yourgene wins Australian approval for chemotherapy toxicity screening assay